Iron Metabolism Disorders
"Iron Metabolism Disorders" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Disorders in the processing of iron in the body: its absorption, transport, storage, and utilization. (From Mosby's Medical, Nursing, & Allied Health Dictionary, 4th ed)
| Descriptor ID |
D019189
|
| MeSH Number(s) |
C18.452.565
|
| Concept/Terms |
Iron Metabolism Disorders- Iron Metabolism Disorders
- Disorder, Iron Metabolism
- Disorders, Iron Metabolism
- Iron Metabolism Disorder
- Metabolism Disorder, Iron
- Metabolism Disorders, Iron
|
Below are MeSH descriptors whose meaning is more general than "Iron Metabolism Disorders".
Below are MeSH descriptors whose meaning is more specific than "Iron Metabolism Disorders".
This graph shows the total number of publications written about "Iron Metabolism Disorders" by people in this website by year, and whether "Iron Metabolism Disorders" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 1 | 0 | 1 |
| 2012 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Iron Metabolism Disorders" by people in Profiles.
-
Clauss M, Dierenfeld E, Goff J, Klasing K, Koutsos L, Lavin S, Livingston S, Nielson B, Schlegel M, Sullivan K, Valdes E, Ward A. IOD in rhinos--nutrition group report: Report from the Nutrition Working Group of the International Workshop on Iron Overload Disorder in Browsing Rhinoceros (February 2011). J Zoo Wildl Med. 2012 Sep; 43(3 Suppl):S108-13.
-
Mylniczenko ND, Sullivan KE, Corcoran ME, Fleming GJ, Valdes EV. Management strategies of iron accumulation in a captive population of black rhinoceroses (Diceros bicornis minor). J Zoo Wildl Med. 2012 Sep; 43(3 Suppl):S83-91.
-
Liu G, Men P, Kudo W, Perry G, Smith MA. Nanoparticle-chelator conjugates as inhibitors of amyloid-beta aggregation and neurotoxicity: a novel therapeutic approach for Alzheimer disease. Neurosci Lett. 2009 May 22; 455(3):187-90.